Last 12 months
Inside the activity.
0 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 19, 2018 Filed Jun 20, 2018 22:25 UTC |
Ngo Nhat HEVP, Marketing, S & B D
|
SaleCommon Stock | 4,114 | $52.00 | $213,946.10 |
DisclosureSEC source: 0001179110-18-008858 · edgar.xml · nonDerivative · entry 2 Ngo Nhat H · CIK 0001305020 · EVP, Marketing, S & B D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,750 F1 · price: The price reported in Column 4 is the average price of $52.0044. The sold price range was between $51.15 to $52.25. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 19, 2018 Filed Aug 23, 2018 22:58 UTC Amendment |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
Exercise / conversionStock Options NQ (right to Buy) · Derivative | 18,154 | $0.00 Strike: $25.08 | $0.00 |
DisclosureSEC source: 0001179110-18-010845 · edgar.xml · derivative · entry 7 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,154 Underlying: Common Stock · 18,154 shares Expires 2025-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| June 19, 2018 Filed Aug 23, 2018 22:58 UTC Amendment |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 18,154 | $52.00 | $944,008.00 |
DisclosureSEC source: 0001179110-18-010845 · edgar.xml · nonDerivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,265 F3 · price: The price reported in Column 4 is the exact price of $52.00 the shares sold. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 19, 2018 Filed Aug 23, 2018 22:58 UTC Amendment |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
Exercise / conversionCommon Stock | 18,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-010845 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| June 19, 2018 Filed Aug 23, 2018 22:58 UTC Amendment |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 9,483 | $52.04 | $493,502.91 |
DisclosureSEC source: 0001179110-18-010845 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,265 F5 · price: The price reported in Column 4 is the Average price of $52.0408. The shares sold between $51.35 to $52.25. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 18, 2018 Filed Jun 18, 2018 21:18 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
Exercise / conversionStock Options NQ (right to Buy) · Derivative | 439 | $0.00 Strike: $25.08 | $0.00 |
DisclosureSEC source: 0001179110-18-008711 · edgar.xml · derivative · entry 7 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 439 Underlying: Common Stock · 439 shares Expires 2025-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| June 18, 2018 Filed Jun 18, 2018 21:18 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 439 | $52.00 | $22,828.00 |
DisclosureSEC source: 0001179110-18-008711 · edgar.xml · nonDerivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,748 F4 · price: The price reported in Column 4 is the exact price of $52.00 the shares sold. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 18, 2018 Filed Jun 18, 2018 21:18 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
Exercise / conversionCommon Stock | 439 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-008711 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,187 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 21:21 UTC |
Seim Robin GenePresident, Global A & M A
|
Tax withholdingCommon Stock | 4,101 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-008718 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,020 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 21:21 UTC |
Seidelmann Scott PeterEVP, Chief Commercial Officer
|
Tax withholdingCommon Stock | 769 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-008717 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,231 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 21:21 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
Tax withholdingCommon Stock | 1,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-008716 · edgar.xml · nonDerivative · entry 2 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,459 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 21:20 UTC |
SPEARS JOSEPH BRIANChief Accounting Officer & VP
|
Tax withholdingCommon Stock | 173 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-008715 · edgar.xml · nonDerivative · entry 2 SPEARS JOSEPH BRIAN · CIK 0001729964 · Chief Accounting Officer & VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,709 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 21:20 UTC |
Kuipers Peter J.Executive V P& CFO
|
Tax withholdingCommon Stock | 2,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-008714 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,370 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 21:20 UTC |
Ngo Nhat HEVP, Marketing, S & B D
|
Tax withholdingCommon Stock | 2,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-008713 · edgar.xml · nonDerivative · entry 2 Ngo Nhat H · CIK 0001305020 · EVP, Marketing, S & B D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,864 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 21:19 UTC |
Taborga Jorge R.EVP, Global R & D
|
Tax withholdingCommon Stock | 1,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-008712 · edgar.xml · nonDerivative · entry 2 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,930 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 21:18 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
Tax withholdingCommon Stock | 10,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-008711 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,748 F3 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 06, 2018 Filed Jun 6, 2018 22:43 UTC |
Kuipers Peter J.Executive V P& CFO
|
Exercise / conversionStock Options NQ (right to buy) · Derivative | 8,781 | $0.00 Strike: $32.78 | $0.00 |
DisclosureSEC source: 0001179110-18-008169 · edgar.xml · derivative · entry 6 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,781 Underlying: Common Stock · 8,781 shares Expires 2025-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2018 Filed Jun 6, 2018 22:43 UTC |
Kuipers Peter J.Executive V P& CFO
|
Exercise / conversionStock Options NQ (right to Buy) · Derivative | 363 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-18-008169 · edgar.xml · derivative · entry 5 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 363 Underlying: Common Stock · 363 shares Expires 2026-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2018 Filed Jun 6, 2018 22:43 UTC |
Kuipers Peter J.Executive V P& CFO
|
SaleCommon Stock | 363 | $49.57 | $17,994.31 |
DisclosureSEC source: 0001179110-18-008169 · edgar.xml · nonDerivative · entry 4 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,970 F1 · price: The price reported in Column 4 is the average price of $49.5711 and the shares sold between $49.555 to $49.65. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 06, 2018 Filed Jun 6, 2018 22:43 UTC |
Kuipers Peter J.Executive V P& CFO
|
SaleCommon Stock | 8,781 | $49.57 | $435,283.83 |
DisclosureSEC source: 0001179110-18-008169 · edgar.xml · nonDerivative · entry 3 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,333 F1 · price: The price reported in Column 4 is the average price of $49.5711 and the shares sold between $49.555 to $49.65. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 06, 2018 Filed Jun 6, 2018 22:43 UTC |
Kuipers Peter J.Executive V P& CFO
|
Exercise / conversionCommon Stock | 9,144 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-008169 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,114 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2018 Filed Jun 5, 2018 21:57 UTC |
DREW J CHRISTOPHERPresident, North American A&A
|
Exercise / conversionStock Options NQ (right to Buy) · Derivative | 9,401 | $0.00 Strike: $12.48 | $0.00 |
DisclosureSEC source: 0001179110-18-008115 · edgar.xml · derivative · entry 5 DREW J CHRISTOPHER · CIK 0001271482 · President, North American A&A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,401 Underlying: Common Stock · 9,401 shares Expires 2020-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2018 Filed Jun 5, 2018 21:57 UTC |
DREW J CHRISTOPHERPresident, North American A&A
|
SaleCommon Stock | 9,401 | $50.18 | $471,777.90 |
DisclosureSEC source: 0001179110-18-008115 · edgar.xml · nonDerivative · entry 4 DREW J CHRISTOPHER · CIK 0001271482 · President, North American A&A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,539 F1 · price: The price reported in Column 4 is the average price of $50.1838. The shares traded between $50.00 to $50.60. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Christopher Drew is no longer an Officer of Omnicell. His termination date was April 2, 2018. This is the last Form 4. Read SEC document |
| June 05, 2018 Filed Jun 5, 2018 21:57 UTC |
DREW J CHRISTOPHERPresident, North American A&A
|
Exercise / conversionCommon Stock | 9,401 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-008115 · edgar.xml · nonDerivative · entry 3 DREW J CHRISTOPHER · CIK 0001271482 · President, North American A&A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,940 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2018 Filed Jun 4, 2018 22:03 UTC |
Seim Robin GenePresident, Global A & M A
|
Exercise / conversionStock Options NQ (right to Buy) · Derivative | 4,912 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-18-007985 · edgar.xml · derivative · entry 6 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,912 Underlying: Common Stock · 4,912 shares Expires 2027-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2018 Filed Jun 4, 2018 22:03 UTC |
Seim Robin GenePresident, Global A & M A
|
Exercise / conversionStock Options NQ (right to Buy) · Derivative | 1,312 | $0.00 Strike: $36.70 | $0.00 |
DisclosureSEC source: 0001179110-18-007985 · edgar.xml · derivative · entry 5 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,312 Underlying: Common Stock · 1,312 shares Expires 2028-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2018 Filed Jun 4, 2018 22:03 UTC |
Seim Robin GenePresident, Global A & M A
|
Exercise / conversionStock Options NQ (right to Buy) · Derivative | 9,434 | $0.00 Strike: $36.70 | $0.00 |
DisclosureSEC source: 0001179110-18-007985 · edgar.xml · derivative · entry 4 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,434 Underlying: Common Stock · 9,434 shares Expires 2028-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2018 Filed Jun 4, 2018 22:03 UTC |
Seim Robin GenePresident, Global A & M A
|
SaleCommon Stock | 15,658 | $48.00 | $751,584.00 |
DisclosureSEC source: 0001179110-18-007985 · edgar.xml · nonDerivative · entry 3 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,121 F1 · price: The price reported in Column 4 is the Exact price of $48.00. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 04, 2018 Filed Jun 4, 2018 22:03 UTC |
Seim Robin GenePresident, Global A & M A
|
Exercise / conversionCommon Stock | 15,658 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-007985 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| May 17, 2018 Filed May 17, 2018 21:45 UTC Amendment |
PETERSMEYER GARY SDirector
|
SaleCommon Stock | 1,650 | $46.13 | $76,106.25 |
DisclosureSEC source: 0001179110-18-007055 · edgar.xml · nonDerivative · entry 2 PETERSMEYER GARY S · CIK 0001206986 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,253 F2 · shares: Coded wrong as A, it should be S for sale. F1 · price: The price reported in Column 4 is the exact price of $46.1250. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 17, 2018 Filed May 17, 2018 21:26 UTC |
PETERSMEYER GARY SDirector
|
SaleCommon Stock | 1,650 | $46.13 | $76,106.25 |
DisclosureSEC source: 0001179110-18-007047 · edgar.xml · nonDerivative · entry 2 PETERSMEYER GARY S · CIK 0001206986 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,253 F1 · price: The price reported in Column 4 is the exact price of $46.1250. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 15, 2018 Filed May 16, 2018 17:30 UTC |
WHITE SARA JDirector
|
GrantCommon Stock | 3,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006862 · edgar.xml · nonDerivative · entry 2 WHITE SARA J · CIK 0001227559 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,668 F1 · shares: Grant of restricted shares in consideration of services as a Board Member. Shares shall vest in full on the date of the Company's 2019 Annual Meeting of Stockholders. Read SEC document |
| May 15, 2018 Filed May 16, 2018 17:30 UTC |
Moore Vance B.Director
|
GrantCommon Stock | 2,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006861 · edgar.xml · nonDerivative · entry 2 Moore Vance B. · CIK 0001550553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,447 F1 · shares: Grant of restricted shares in consideration of services as a Board Member. Shares shall vest in full on the date of the Company's 2019 Annual Meeting of Stockholders Read SEC document |
| May 15, 2018 Filed May 16, 2018 17:30 UTC |
Bauer Joanne BDirector
|
GrantCommon Stock | 2,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006860 · edgar.xml · nonDerivative · entry 2 Bauer Joanne B · CIK 0001359343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,314 F1 · shares: Grant of restricted shares in consideration of services as a member of the Board of Directors. Shares vest in full on the date of the Company's 2019 Annual Meeting of Stockholders. Read SEC document |
| May 15, 2018 Filed May 16, 2018 17:29 UTC |
PARRISH MARK WDirector
|
GrantCommon Stock | 2,735 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006859 · edgar.xml · nonDerivative · entry 2 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,397 F1 · shares: Grant of restricted shares in consideration of service as a Board member. Shares shall vest in full on the date of the Company's 2019 Annual Meeting of Stockholders. Read SEC document |
| May 15, 2018 Filed May 16, 2018 17:29 UTC |
Judson James TDirector
|
GrantCommon Stock | 3,379 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006858 · edgar.xml · nonDerivative · entry 2 Judson James T · CIK 0001326789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,952 F1 · shares: Grant of restricted shares in consideration of service as a Board member. Shares shall vest in full on the date of the Company's 2019 Annual Meeting of Stockholders. Read SEC document |
| May 15, 2018 Filed May 16, 2018 17:29 UTC |
Smith Bruce D.Director
|
GrantCommon Stock | 2,735 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006857 · edgar.xml · nonDerivative · entry 2 Smith Bruce D. · CIK 0001635537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,223 F1 · shares: Grant of restricted shares in consideration of service as a Board member. Shares shall vest in full on the date of the Company's 2019 Annual Meeting of Stockholders. Read SEC document |
| May 15, 2018 Filed May 16, 2018 17:28 UTC |
PETERSMEYER GARY SDirector
|
GrantCommon Stock | 3,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006856 · edgar.xml · nonDerivative · entry 2 PETERSMEYER GARY S · CIK 0001206986 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,903 F1 · shares: Grant of restricted shares in consideration of service as a Board member. Shares shall vest in full on the date of the Companys 2019 Annual Meeting of Stockholders. Read SEC document |
| May 15, 2018 Filed May 16, 2018 15:01 UTC |
Seim Robin GenePresident, Global A & M A
|
Exercise / conversionStock Options NQ (right to Buy) · Derivative | 10,156 | $0.00 Strike: $34.02 | $0.00 |
DisclosureSEC source: 0001179110-18-006846 · edgar.xml · derivative · entry 5 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,156 Underlying: Common Stock · 10,156 shares Expires 2025-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2018 Filed May 16, 2018 15:01 UTC |
Seim Robin GenePresident, Global A & M A
|
Exercise / conversionStock Options NQ (right to Buy) · Derivative | 3,130 | $0.00 Strike: $25.08 | $0.00 |
DisclosureSEC source: 0001179110-18-006846 · edgar.xml · derivative · entry 4 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,130 Underlying: Common Stock · 3,130 shares Expires 2024-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2018 Filed May 16, 2018 15:01 UTC |
Seim Robin GenePresident, Global A & M A
|
SaleCommon Stock | 13,286 | $46.48 | $617,523.98 |
DisclosureSEC source: 0001179110-18-006846 · edgar.xml · nonDerivative · entry 3 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,121 F1 · price: The price reported in Column 4 is the average price of $46.4793. The shares sold between $46.15 to $46.80. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 15, 2018 Filed May 16, 2018 15:01 UTC |
Seim Robin GenePresident, Global A & M A
|
Exercise / conversionCommon Stock | 13,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006846 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · President, Global A & M A 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| May 11, 2018 Filed May 14, 2018 15:40 UTC |
Kuipers Peter J.Executive V P& CFO
|
Exercise / conversionStock Options NQ (right to buy) · Derivative | 2,000 | $0.00 Strike: $32.78 | $0.00 |
DisclosureSEC source: 0001179110-18-006686 · edgar.xml · derivative · entry 6 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2025-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2018 Filed May 14, 2018 15:40 UTC |
Kuipers Peter J.Executive V P& CFO
|
Exercise / conversionStock Options NQ (right to Buy) · Derivative | 1,456 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-18-006686 · edgar.xml · derivative · entry 5 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,456 Underlying: Common Stock · 1,456 shares Expires 2026-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2018 Filed May 14, 2018 15:40 UTC |
Kuipers Peter J.Executive V P& CFO
|
SaleCommon Stock | 2,000 | $47.61 | $95,229.00 |
DisclosureSEC source: 0001179110-18-006686 · edgar.xml · nonDerivative · entry 4 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,970 F1 · price: The price reported in Column 4 is the average price of $47.6145. The shares sold between $47.60 to $47.6550. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2018 Filed May 14, 2018 15:40 UTC |
Kuipers Peter J.Executive V P& CFO
|
SaleCommon Stock | 1,456 | $47.62 | $69,333.26 |
DisclosureSEC source: 0001179110-18-006686 · edgar.xml · nonDerivative · entry 3 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,970 F2 · price: The price reported in Column 4 is the exact price of $47.6190. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2018 Filed May 14, 2018 15:40 UTC |
Kuipers Peter J.Executive V P& CFO
|
Exercise / conversionCommon Stock | 3,456 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006686 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 20, 2018 Filed Apr 23, 2018 17:20 UTC |
Seidelmann Scott PeterEVP, Chief Commercial Officer
|
GrantStock Options NQ (Right to Buy) · Derivative | 68,000 | $0.00 Strike: $43.30 | $0.00 |
DisclosureSEC source: 0001179110-18-005813 · edgar.xml · derivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,000 Underlying: Common Stock · 68,000 shares Expires 2028-04-19 F2 · shares: NQ Options shall vest ratably over 48 month period, with a year cliff. Read SEC document |
| April 20, 2018 Filed Apr 23, 2018 17:20 UTC |
Seidelmann Scott PeterEVP, Chief Commercial Officer
|
GrantCommon Stock | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-005813 · edgar.xml · nonDerivative · entry 1 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 F1 · shares: Restricted Stock Units shall vest semiannually on 6/15 and 12/15 over a 4 year period. Read SEC document |
| April 16, 2018 Filed Apr 16, 2018 21:57 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
Exercise / conversionStock Options NQ (right to Buy) · Derivative | 6,250 | $0.00 Strike: $25.08 | $0.00 |
DisclosureSEC source: 0001179110-18-005696 · edgar.xml · derivative · entry 5 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 6,250 shares Expires 2024-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.